Category:
Pandemic
Latest
Govt prioritising vaccinating eligible people in UP, Punjab: Report
The cumulative COVID-19 vaccine doses administered in the country crossed 78 crore on Friday. The government said 20 per cent of India’s adult population have received both doses of COVID-19 vaccine and 62 per cent have got at least one dose.
Of all the vaccines used, around 87.8 per cent are Covishield manufactured by Serum Institute, around 12.11 per cent are Bharat Biotech’s Covaxin and less than one per cent Sputnik V.
Adherence to COVID-19-appropriate behaviour during festive season key to prevent 3rd wave: Experts
”Currently, there is a declining trend of COVID-19 cases and we are in a pretty good situation. However, the coming few weeks with the festive season ongoing and with that associated changes of decrease in Covid-appropriate behavior, large gatherings, and super-spreading events can be a deciding factor for the third wave,” AIIMS Director Randeep Guleria said.
He said the next two-three months are crucial in terms of preventive strategies for the country to continue to be in a good position.
Private investigators’ body APDI forms global alliance against fake Covid-19 vaccines
APDI Chairman Kunwar Vikram Singh in a statement said, “The GAFV has been formed after reports emanating from several countries about the circulation of fake Covid vaccines. Already, Europol, the European Union’s law enforcement agency, has issued a warning of fake vaccine circulation due to huge demands.”
WHO calls for intensified measures over ‘alarming’ virus variant
“This is an alarming situation, which means that for a short period of time we need to do more than we have done and to intensify the public health and social measures to be certain we can flatten the steep vertical line in some countries,” WHO’s regional director for Europe Hans Kluge, said, referring primarily to the new variant first discovered in the UK.
4,400 adverse events reported in US after receiving Pfizer-BioNTech vaccine
Locations administering Covid-19 vaccines should adhere to CDC guidance for use of the jabs, including screening recipients for contraindications and precautions, having the necessary supplies available to manage anaphylaxis, implementing the recommended post-vaccination observation periods, and immediately treating suspected cases of anaphylaxis with an intramuscular injection of epinephrine, said the CDC
Centre ready to pay vaccination cost in 1st phase: Maharashtra health minister Rajesh Tope
“We are going to set up vaccination centres at state and civic-run hospitals. If we could set up 100 such centres with each catering to 100 persons, we can cover the entire health staff in 70 to 80 days,” the minister said.
Moderna CEO says vaccine likely to protect for ‘couple of years’
“The nightmare scenario that was described in the media in the spring with a vaccine only working a month or two is, I think, out of the window.The antibody decay generated by the vaccine in humans goes down very slowly (…) We believe there will be protection potentially for a couple of years,” Moderna CEO Stephane Bancel said
Pfizer/BioNTech vaccine appears effective against mutation in new coronavirus variants -study
The Pfizer/BioNTech vaccine and the one from Moderna Inc, which use synthetic messenger RNA technology, can be quickly tweaked to address new mutations of a virus if necessary. Scientists have suggested the changes could be made in as little as six weeks.
Health min warns people against fake Co-WIN apps, says govt-approved app will be launched soon
”Some apps named ‘Co-WIN’ apparently created by unscrupulous elements to sound similar to upcoming official platform of Government, are on Appstores. DO NOT download or share personal information on these. MoHFW Official platform will be adequately publicised on its launch,” the Union Health ministry tweeted.
Peruvian minister raises ‘controversy’ over Pfizer vaccine liability clause
Several other countries, including Brazil and Argentina, have raised concerns about liability waivers in their negotiations with Pfizer.
World Bank officials said on Tuesday they were working with countries to address the liability waiver issue which they said had emerged as one of the key obstacles to sealing vaccine supply deals.
Criticism mounts over India’s ‘abrupt’ approval of COVAXIN
Regulators also granted approval to Bharat Biotech’s vaccine only “in clinical trial mode”, unusually cryptic language that left some experts baffled.
All Indian vaccines being developed for storage at 2-8 degree Celsius: DBT secretary
Unlike the Pfizer and Moderna which requires a minus 70 degree celsius (cold) chain, this (the Biological E’s vaccine candidate) is basically at the 2-8 degree Celsius, department of biotechnology secretary Renu Swarup said